End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
33.71 CNY | +1.57% | -2.57% | -37.50% |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The company returns high margins, thereby supporting business profitability.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- The company benefits from high valuations in earnings multiples.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-37.50% | 522M | - | ||
-0.78% | 79.24B | C+ | ||
-17.22% | 32.43B | B- | ||
-10.23% | 31.64B | A- | ||
+2.76% | 17.65B | B | ||
+1.65% | 14.62B | B+ | ||
-12.56% | 12.03B | B+ | ||
+4.64% | 7.86B | B- | ||
-18.25% | 6.92B | B | ||
+3.95% | 3.61B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- 688157 Stock
- Ratings Sokan New Materials Group Co., Ltd.